Kardigan Inc. (KARD)
NASDAQ: KARDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
KARD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.08B
- EPS (TTM)
- -$6.24
- Dividend yield
- None
- 52-week range
- 11.49 – 27.00
- Day range
- 11.49 – 12.77
- Volume / Avg
- 459.24K / 625.83K
- Beta
- —
- Shares outstanding
- 93.60M
52-week range
KARD stock today
Shares of Kardigan (KARD) finished lower on Nov 20 at $11.54, a drop of 7.83% or $0.98 per share, versus the S&P 500's 3.70% decline. At this level, KARD sits near the bottom of its 52-week range of $11.49 to $27.00: 57.3% below the high, set on Jun 29, 2026 and 0.4% above the low. Kardigan has posted a net loss over the last twelve months (EPS of -$6.24), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Kardigan
Company profileKardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Tassos Anastasios E. Gianakakos M.Sc., MBA
- Headquarters
- Princeton, NJ
- Employees
- 241
- IPO year
- 2026
- Website
- kardigan.bio
Analyst forecast
ForecastConsensus (9 analysts)
strong_buy
Avg. price target
$41.00+255.29%
- Strong buy 1
- Buy 8
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 12, 2026
- EPS actual vs est.
- $-0.64 vs $-0.80
- Surprise
- +20.00%
KARD news
All KARD newsKardigan peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| JBIOJade Biosciences Inc. | 15.31 | +1.66% | $1.06B | vs KARD |
| AAPGAscentage Pharma Group International American Depository Shares | 11.97 | -3.78% | $1.12B | vs KARD |
| NKTRNektar Therapeutics | 30.20 | -7.19% | $1.03B | vs KARD |
| CTYCity Therapeutics Inc. | 19.32 | +5.29% | $1.03B | vs KARD |
| CMPSCOMPASS Pathways Plc American Depository Shares | 8.05 | -6.94% | $1.14B | vs KARD |
| HROWHarrow Inc. | 30.41 | -5.35% | $1.14B | vs KARD |
| ANROAlto Neuroscience Inc. | 25.37 | -4.30% | $1.02B | vs KARD |
| GPCRStructure Therapeutics Inc. ADR | 16.13 | -5.78% | $1.15B | vs KARD |
Indexes, lists and sector
Kardigan stock FAQ
What is Kardigan's stock price today?
KARD last traded at $11.54 as of Nov 20, 4:00 PM EST, down 7.83% on the day. Prices are delayed at least 15 minutes.
Who is Kardigan's CEO?
Mr. Tassos Anastasios E. Gianakakos M.Sc., MBA is the chief executive officer of Kardigan Inc., which has about 241 employees.
What is the KARD 52-week high?
The 52-week high for KARD is $27.00 and the 52-week low is $11.49. The stock is currently 57.3% below its high.